CORRECTED: Novartis Wants Janssen Barred From Disparaging Rival Drug
Novartis Pharmaceuticals Corp. has asked a D.C. federal court to force Janssen Pharmaceuticals Inc. to stop touting skewed study results that make it seem like Janssen's plaque psoriasis treatment, Tremfya, is...To view the full article, register now.
Already a subscriber? Click here to view full article